Clinical Manifestations of 22q11.2 Deletion Syndrome.
22q11.2 deletion syndrome
Aortic arch abnormalities
Conotruncal abnormalities
Di George syndrome
Journal
Heart failure clinics
ISSN: 1551-7136
Titre abrégé: Heart Fail Clin
Pays: United States
ID NLM: 101231934
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
26
11
2021
Statut:
ppublish
Résumé
DiGeorge syndrome (DGS), also known as "22q11.2 deletion syndrome" (22q11DS) (MIM # 192430 # 188400), is a genetic disorder caused by hemizygous microdeletion of the long arm of chromosome 22. In the last decades, the introduction of fluorescence in situ hybridization assays, and in selected cases the use of multiplex ligation-dependent probe amplification, has allowed the detection of chromosomal microdeletions that could not be previously identified using standard karyotype analysis. The aim of this review is to address cardiovascular and systemic involvement in children with DGS, provide genotype-phenotype correlations, and discuss their medical management and therapeutic options.
Identifiants
pubmed: 34776076
pii: S1551-7136(21)00078-7
doi: 10.1016/j.hfc.2021.07.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-164Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.